FDA accepts Orapem NDA

FDA accepted for filing an NDA for Orapem faropenem from Replidyne (Louisville, Colo.) and Forest (FRX) to treat acute bacterial sinusitis, community-acquired pneumonia (CAP), acute exacerbations of c...